#USA #Pleasanton #Regeneron Pharmaceuticals #Veeva Vault CRM #Commercial Evidence

Regeneron Pharmaceuticals Enhances CRM with Veeva Vault

In a significant move for the biopharmaceutical industry, Regeneron Pharmaceuticals has announced its global commitment to utilizing Veeva Vault Customer Relationship Management (CRM). This decision marks a pivotal moment not only for Regeneron but also for the healthcare landscape as whole.

Veeva Vault CRM is designed to optimize commercial processes through advanced technological features, particularly in generating Commercial Evidence. Regeneron intends to leverage this robust platform to enhance its field engagement strategies, identifying and addressing barriers to treatment adoption. By doing so, they aim to ensure that their innovative medications can effectively reach patients in need.

Ryan Steinberger, the Executive Vice President and Chief Digital and Technology Officer at Regeneron, expressed enthusiasm about this strategic partnership, stating, "We are pleased to expand our strategic partnership with Veeva by moving to Vault CRM, which will give our commercial teams a more connected platform and help them get faster access to the information they need for efficient decision-making."

This integration will streamline communications and data access for Regeneron's commercial teams, thereby improving their responsiveness and efficiency. With Vault CRM, every interaction is transformed into an opportunity to gather insights—previously lost due to traditional compliance concerns.

Matt Farrell, President of Commercial Strategy at Veeva, echoed this sentiment, highlighting the importance of their collaboration. He remarked, "Regeneron uses the power of science to invent, develop, and commercialize life-transforming medicines for people with serious diseases. We are honored to extend our strategic partnership with Regeneron to include Veeva Vault CRM as they continue to deliver important new medicines to people in need.”

The Importance of Commercial Evidence in Biopharma

In the biopharmaceutical field, generating Commercial Evidence is essential for medical companies, as it leads to data-driven decisions that can directly impact patient access to treatments. Veeva Vault CRM stands out with its unique Agentic Call Report feature, which ensures that each field interaction is documented and valuable insights are retained.

As healthcare becomes increasingly data-centric, platforms like Veeva Vault CRM are crucial for companies that wish to excel in customer relationship management while ensuring compliance with industry regulations. By harnessing the power of AI within field engagements, Regeneron can uncover insights related to treatment adoption, paving the way for improved patient outcomes.

Veeva Systems: A Leader in Life Sciences Cloud Solutions

Veeva Systems has established itself as a leader in providing cloud solutions specifically tailored for the life sciences industry. With a commitment to innovation and customer success, they serve over 1,500 clients, ranging from large pharmaceutical companies to emerging biotechs. Their focus on creating comprehensive, user-friendly applications allows clients like Regeneron to optimize their processes and enhance their operational efficiency.

As a Public Benefit Corporation, Veeva emphasizes a holistic approach by balancing the interests of stakeholders across the board. This ethos aligns closely with Regeneron's mission to provide groundbreaking, life-changing treatments for patients worldwide.

In conclusion, Regeneron Pharmaceuticals' selection of Veeva Vault CRM for global use signals a forward-thinking approach aimed at improving patient access to treatments while leveraging advanced technology for operational excellence. As both organizations work closely together, the potential to revolutionize how commercial evidence is generated is immense, setting a new standard for the biopharmaceutical industry.

This partnership not only represents a strategic victory for both companies but also reinforces the critical role that technology plays in advancing healthcare accessibility and efficacy.